Integrin α2β1 targeted GdVO4: Eu ultrathin nanosheet for multimodal PET/MR imaging

Biomaterials

Volumn 35, Issue 30, 2014, Pages 8649-8658

  Hu, He ^a   Li, Dan ^a   Liu, Shuanglong ^a   Wang, Mengzhe ^a   Moats, Rex ^a   Conti, Peter S ^a   Li, Zibo ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

2D nanosheet; Magnetic resonance imaging (MRI); Multimodal imaging; Positron emission tomography (PET)

Indexed keywords

DIAGNOSIS; FLUORESCENCE; NANOPROBES; NANOSHEETS; POSITRON EMISSION TOMOGRAPHY;

CARBOXYL-FUNCTIONALIZED; FLUORESCENT MICROSCOPY; INTEGRINS; MULTI-MODAL IMAGING; MULTIFUNCTIONAL NANOPROBES; PARAMAGNETIC PROPERTIES; PARTICLE DISTRIBUTIONS; POSITRON EMISSION TOMOGRAPHY (PET);

MAGNETIC RESONANCE IMAGING;

ASPARGYLGLYCYLGLUTAMINYLALANINE; CARBOXYL GROUP; CHELATING AGENT; COPPER 64; GADOLINIUM VANADATE EUROPIUM; NANOMATERIAL; OLEIC ACID; PEPTIDE; POLYACRYLIC ACID; RADIOPHARMACEUTICAL AGENT; TETRAXETAN; TWO DIMENSIONAL TETRAGONAL ULTRATHIN NANOSHEET; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2; 1,4,7,10-TETRAAZACYCLODODECANE- 1,4,7,10-TETRAACETIC ACID; ASPARTYL-GLYCYL-GLUTAMYL-ALANINE; EUROPIUM; GADOLINIUM; NANOPARTICLE; OLIGOPEPTIDE; SINGLE HETEROCYCLIC RINGS; VANADIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; EX VIVO STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOUSE; MULTIMODAL IMAGING; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN TARGETING; RADIOACTIVITY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT; ANIMAL; CELL DEATH; CELL SURVIVAL; CHEMISTRY; DIAGNOSTIC USE; DRUG SCREENING; INFRARED SPECTROSCOPY; METABOLISM; NUDE MOUSE; SPECTROFLUOROMETRY; SYNTHESIS; TISSUE DISTRIBUTION; TUMOR CELL LINE; ULTRASTRUCTURE; X RAY DIFFRACTION;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; EUROPIUM; GADOLINIUM; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; INTEGRIN ALPHA2BETA1; MAGNETIC RESONANCE IMAGING; MALE; MICE, NUDE; MULTIMODAL IMAGING; NANOPARTICLES; OLEIC ACID; OLIGOPEPTIDES; POSITRON-EMISSION TOMOGRAPHY; SPECTROMETRY, FLUORESCENCE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TISSUE DISTRIBUTION; VANADATES; X-RAY DIFFRACTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84904733592     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.06.059     Document Type: Article

References (58)

1. Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010, 110:3146-3195.
2. Kim J., Piao Y., Hyeon T. Multifunctional nanostructured materials for multimodal imaging and simultaneous imaging and therapy. Chem Soc Rev 2009, 38:372-390.
3. Campbell R.E., Chang C.J. Molecular imaging. Curr Opin Chem Biol 2009, 14:1-2.
4. Cai W.B., Chen X.Y. Nanoplatforms for targeted molecular imaging in living. Small 2007, 3:1840-1854.
5. Terreno E., Castelli D.D., Viale A., Aime S. Challenges for molecular magnetic resonance imaging. Chem Rev 2010, 110:3019-3042.
6. Liu Y., Welch M.J. Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications. Bioconjug Chem 2012, 23:671-682.
7. Adam M.J., Wilbur D.S. Radiohalogens for imaging and therapy. Chem Soc Rev 2005, 34:153-163.
8. Heilemann M., van de Linde S., Schüttpelz M., Kasper R., Seefeldt B., Mukherjee A., et al. Subdiffraction-resolution fluorescence imaging with conventional fluorescent probes. Angew Chem In Ed 2008, 47:6172-6176.
9. Park K., Lee S., Kang E., Kim K., Choi K., Kwon I.C. New generation of multifunctional nanoparticles for cancer imaging and therapy. Adv Funct Mater 2009, 19:1553-1566.
10. Liu Q., Sun Y., Li C., Zhou J., Li C., Yang T., et al. 18F-Labeled magnetic-upconversion nanophosphors via rare-earth cation-Assisted ligand assembly. ACS Nano 2011, 5:3146-3157.
11. 4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials 2011, 32:1148-1156.
12. Cai W., Chen K., Li Z.-B., Gambhir S.S., Chen X. Dual-function probe for PET and near-Infrared fluorescence imaging of tumor vasculature. J Nucl Med 2007, 48:1862-1870.
13. Ducongé Fdr, Pons T., Pestourie C., Hérin L., Thézé B., Gombert K., et al. Fluorine-18-labeled phospholipid quantum dot micelles for in vivo multimodal imaging from whole body to cellular scales. Bioconjug Chem 2008, 19:1921-1926.
14. Yang H., Zhuang Y., Hu H., Du X., Zhang C., Shi X., et al. Silica-coated manganese oxide nanoparticles as a platform for targeted magnetic resonance and fluorescence imaging of cancer cells. Adv Funct Mater 2010, 20:1733-1741.
15. Zhou J., Sun Y., Du X., Xiong L., Hu H., Li F. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared tonear-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials 2010, 31:3287-3295.
16. 2 core-shell nanoprobes for targeted magnetic resonance imaging. Nanoscale 2013, 5:10447-10454.
17. 4 nanocrystals. Adv Funct Mater 2009, 19:853-859.
18. 64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J Am Chem Soc 2010, 132:15351-15358.
19. Kwee T., Basu S., Cheng G., Alavi A. FDG PET/CT in carcinoma of unknown primary. Eur J Nucl Med Mol Imaging 2010, 37:635-644.
20. 64Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. Bioconjug Chem 2010, 21:715-722.
21. Choi J.-s., Park J.C., Nah H., Woo S., Oh J., Kim K.M., et al. A hybrid nanoparticle probe for dual-Modality positron emission tomography and magnetic resonance imaging. Angew Chem In Ed 2008, 47:6259-6262.
22. Xie J., Chen K., Huang J., Lee S., Wang J., Gao J., et al. PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 2010, 31:3016-3022.
23. Stelter L., Pinkernelle J., Michel R., Schwartländer R., Raschzok N., Morgul M., et al. Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging. Mol Imaging Biol 2010, 12:25-34.
24. Bouzigues C., Gacoin T., Alexandrou A. Biological applications of rare-earth based nanoparticles. ACS Nano 2011, 5:8488-8505.
25. Bunzli J.-C.G. Lanthanide luminescence for biomedical analyses and imaging. Chem Rev 2010, 110:2729-2755.
26. 4 compounds. Inorg Chim Acta 1996, 248:85-88.
27. Ropp R.C. Spectra of some rare earth vanadates. J Electrochem Soc 1968, 115:940-945.
28. 4 phosphors. Appl Phys A 2002, 74:153-162.
29. 3+ (Ln = Sm, Dy, Er) sub-micrometer phosphors. J Mater Sci Mater Electron 2011, 22:1330-1334.
30. 1 MRI contrast agents. J Mater Chem 2009, 19:6267-6273.
31. Jun Yw, Choi Js, Cheon J. Shape control of semiconductor and metal oxide nanocrystals through nonhydrolytic colloidal routes. Angew Chem In Ed 2006, 45:3414-3439.
32. Qi L. Colloidal chemical approaches to inorganic micro- and nanostructures with controlled morphologies and patterns. Coord Chem Rev 2010, 254:1054-1071.
33. Tung V.C., Allen M.J., Yang Y., Kaner R.B. High-throughput solution processing of large-scale graphene. Nat Nano 2009, 4:25-29.
34. 3 nanoplates with bright upconversion luminescence. Nanotechnology 2008, 19:375702-375710.
35. Zhang Q., Yan B. Salt-effect-based synthesis and anomalous magnetic properties of rare-earth oxide nanosheets with sub-1 nm thickness. Chem Eur J 2012, 18:5150-5154.
36. 4. Inorg Mater 2008, 44:1121-1124.
37. 4 upconversion nanophosphors with tunable emissions and their applications for biomedical imaging. J Mater Chem 2012, 22:6974-6981.
38. Liu J., Li Y. General synthesis of colloidal rare earth orthovanadate nanocrystals. J Mater Chem 2007, 17:1797-1803.
39. Hu H., Zhou H., Du J., Wang Z., An L., Yang H., et al. Biocompatiable hollow silica microspheres as novel ultrasound contrast agents for in vivo imaging. J Mater Chem 2011, 21:6576-6583.
40. Quinn M., Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 2002, 90:162-173.
41. 1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br J Cancer 2006, 94:1311-1319.
42. 1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide. Bioconjug Chem 2011, 22:256-263.
43. 1-targeted probe for microPET imaging of prostate cancer. Eur J Nucl Med Mol Imaging 2011, 38:1313-1322.
44. 1 in prostate cancer with cell-penetrating-peptide-conjugated DGEA probe. J Nucl Med 2011, 52:1979-1986.
45. 1 integrin-targeted peptide probes for prostate cancer imaging. Mol Imaging 2011, 10:284-294.
46. Dong A., Ye X., Chen J., Kang Y., Gordon T., Kikkawa J.M., et al. A generalized ligand-exchange strategy enabling sequential surface functionalization of colloidal nanocrystals. J Am Chem Soc 2011, 133:998-1006.
47. Hennig A., Borcherding H., Jaeger C., Hatami S., Würth C., Hoffmann A., et al. Scope and limitations of surface functional group quantification methods: exploratory study with poly(acrylic acid)-grafted micro- and nanoparticles. J Am Chem Soc 2012, 134:8268-8276.
48. Bioconjugate techniques 2008, Academic Press, San Diego, CA. 2nd ed. G.T. Hermanson (Ed.).
49. Xiong L., Yang T., Yang Y., Xu C., Li F. Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 2010, 31:7078-7085.
50. Yong K.-T., Roy I., Ding H., Bergey E.J., Prasad P.N. Biocompatible near-infrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications. Small 2009, 5:1997-2004.
51. Höppe H.A. Recent developments in the field of inorganic phosphors. Angew Chem In Ed 2009, 48:3572-3582.
52. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 2006, 35:512-523.
53. 1 contrast. Nat Nano 2010, 5:815-821.
54. Bloembergen N., Morgan L.O. Proton relaxation times in paramagnetic solutions. effects of electron spin relaxation. J Chem Phys 1961, 34:842-850.
55. Solomon I. Relaxation processes in a system of two spins. Phys Rev 1955, 99:559-565.
56. Volpes R., van den Oord J.J., Desmet V.J. Distribution of the VLA family of integrins in normal and pathological human liver tissue. Gastroenterology 1991, 101:200-206.
57. Sheppard D., Yokosaki Y. Roles of airway epithelial integrins in health and disease. CHEST J 1996, 109:29S-33S.
58. Clarke M.R., Landreneau R.J., Finkelstein S.D., Wu T.T., Ohori P., Yousem S.A. Extracellular matrix expression in metastasizing and nonmetastasizing adenocarcinomas of the lung. Hum Pathol 1997, 28:54-59.